9:00 – 10:00 Welcome coffee and sweets
10:00 – 10:15 Welcome by MEDVIA
10:15 – 10:45 Gene therapy: current and future treatment modalities, Katherine High, AskBio
10:45 – 11:10 Clinical development and regulatory challenges, Willeke van Roon, DCRT
11:10 – 12:10 Round table: “The value of gene therapy and how to secure access for patients”, Steven Simoens (KU Leuven), Eva Schoeters (RaDiOrg), Dirk Vandermijnsbrugge (Pfizer), Ingrid Maes (Innovigate), Bart Leroy (UZ Gent), and moderated by Ann Van Gysel (MEDVIA)
12:10 – 12:35 Challenges in manufacturing, Morgan O’Brien, Janssen Pharmaceutica
12:35 – 13:45 Lunch and networking exhibitionrm